News

Post image for GMA Is Live On Biocompare

We are officially LIVE on Biocompare! All of our validated, unique antibodies are available to view at Green Mountain Antibodies’ Biocompare webpage. To learn more about our antibodies to control antigens, human plasma antigens, and mouse antigens, go to our Buy Antibodies webpage or contact ProductSales@greenmoab.com.

{ 0 comments }

From May 3rd to 5th, Kaitlyn Begins will be attending the Protein Engineering Summit (PEGS) at the Seaport World Trade Center in Boston, Massachusetts. Kaitlyn will be going to expand Green Mountain Antibodies’ knowledge of engineering antibodies for expression in mammalian cells. She will also be focusing on talks relating to new biologics and therapeutics for infectious disease. If you would like to schedule a time to meet with Kaitlyn at the PEGS, you can reach her at Kaitlyn@greenmoab.com.

{ 0 comments }

GMA Announces Production and Distribution Agreement with African Livestock Research Institute

April 20, 2017
Thumbnail image for GMA Announces Production and Distribution Agreement with African Livestock Research Institute

  Green Mountain Antibodies has signed an agreement with the International Livestock Research Institute (ILRI) of Nairobi, Kenya to produce and distribute monoclonal antibodies that detect infectious disease markers in cattle. This agreement is a result of a collaboration between Green Mountain Antibodies, ILRI, Dr. John Barlow of the University of Vermont, and Dr. Bill […]

Read the full article →

New Additions to Our Anti-Factor VIII Product Line

April 10, 2017
Thumbnail image for New Additions to Our Anti-Factor VIII Product Line

Green Mountain Antibodies is excited to announce the addition of four new antibodies to our already extensive anti-factor VIII antibody collection. Information on GMA-8027, GMA-8040, GMA-8041, and GMA-8045, as well as the full collection, can be viewed here:  http://greenmoab.com/product-category/factor-viii/.  Are there antibodies we’re missing that you need for your research project?  Let us know at […]

Read the full article →

Scientists at GMA Collaborate on Bovine Cytokine Project

October 11, 2016

Scientists at Green Mountain Antibodies have recently collaborated with the USDA and the University of Vermont to produce novel murine monoclonal antibodies to bovine cytokines IL-13 and IL-17A. IL-13 induces B-cell activation and proliferation and possesses anti-inflammatory properties, while IL-17A is primarily responsible for the proinflammatory mechanisms of chronic inflammatory states. Monoclonal antibodies were generated […]

Read the full article →

Congrats to Long-Time GMA Collaborators

August 8, 2016
Thumbnail image for Congrats to Long-Time GMA Collaborators

The recent Nature Medicine publication, ‘A rapid pro-hemostatic approach to overcome direct oral anticoagulants,’ addresses the growing need for effective and clinically viable drugs that control bleeding after anticoagulant administration. Researchers at The Children’s Hospital of Philadelphia have developed a potent variant, designated Factor Xa(I16L), that significantly reduces bleeding and restores normal hemostatic processes. Congratulations […]

Read the full article →

GMA Antibodies Featured in Blood Publication

August 4, 2016
Thumbnail image for GMA Antibodies Featured in Blood Publication

The recent Blood article, ‘Prophylactic efficacy of BeneFIX vs Alprolix in hemophilia B mice,’ features three GMA antibodies. Antibodies to human Factor IX (GMA-101), human Factor X (GMA-540), and human Factor VII (GMA-213) were used in combination with an anti-collagen antibody to demonstrate localization of coagulation factors in human tissues. The study finds that not […]

Read the full article →

New Additions to Our Anti-Factor IX Product Line

July 26, 2016
Thumbnail image for New Additions to Our Anti-Factor IX Product Line

Green Mountain Antibodies is excited to announce the expansion of our anti-Factor IX product line of monoclonal antibodies. Thank you to all of our collaborators who have helped us in determining specificities of interest and testing products in the developmental stage; our line now contains an additional 6 antibodies with more detailed information on the […]

Read the full article →

Gordon Research Conference on Hemostasis

July 20, 2016
Thumbnail image for Gordon Research Conference on Hemostasis

From July 24th to 29th, Amy Griffiths and Dr. Bill Church will be attending the Gordon Research Conference on Hemostasis at the Stoweflake Conference Center, located in Stowe, VT. They will be participating in discussions on a variety of conference topics, including the relationship between Von Willebrand Factor and Factor VIII and the role of […]

Read the full article →

New Antibodies to S. aureus virulence factors to be discussed at American Society of Microbiology meeting in Boston, June 2016.

May 3, 2016

In collaboration with Drs. Paul Bock and Ashok Maddur of Vanderbilt University, and Dr. Pete Panizzi of Auburn University, Green Mountain Antibodies scientists have prepared monoclonal antibodies to the major known procoagulant virulence factors from S. aureus: coagulase and von Willebrand factor binding protein.  The rationale behind preparing these antibodies is the hypothesis that blocking […]

Read the full article →